Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1995 1
2004 1
2005 1
2006 1
2008 1
2009 1
2014 1
2016 4
2018 1
2019 3
2020 4
2021 2
2022 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Sex in Respiratory and Skin Allergies.
Ridolo E, Incorvaia C, Martignago I, Caminati M, Canonica GW, Senna G. Ridolo E, et al. Among authors: incorvaia c. Clin Rev Allergy Immunol. 2019 Jun;56(3):322-332. doi: 10.1007/s12016-017-8661-0. Clin Rev Allergy Immunol. 2019. PMID: 29306980 Review.
The role of allergoids in allergen immunotherapy: from injective to sublingual route.
Compalati E, Incorvaia C, Cavaliere C, Masieri S, Gargiulo A, Mistrello G, Frati F. Compalati E, et al. Among authors: incorvaia c. Eur Ann Allergy Clin Immunol. 2020 Sep;52(5):195-204. doi: 10.23822/EurAnnACI.1764-1489.142. Epub 2020 Sep 8. Eur Ann Allergy Clin Immunol. 2020. PMID: 32338477 Free article. Review.
In the first allergoids glutaraldehyde or formaldehyde were used as cross-linking agent to polymerize allergens, this resulting in high molecular weight molecules (200,000 to 20,000,000 daltons) which were significantly less allergenic due to a decreased capacity to bridge IgE on …
In the first allergoids glutaraldehyde or formaldehyde were used as cross-linking agent to polymerize allergens, this resulting in high mole …
Prevention of post-contrast kidney injury in patients with cancer.
Grassedonio E, Incorvaia L, Guarneri M, Guagnini F, Midiri M. Grassedonio E, et al. Among authors: incorvaia l. Drugs Context. 2024 Mar 14;13:2023-11-2. doi: 10.7573/dic.2023-11-2. eCollection 2024. Drugs Context. 2024. PMID: 38510312 Free PMC article. Review.
Post-contrast acute kidney injury is defined as a nephropathy with an increase in serum creatinine of >0.3 mg/dL (or >26.5 mumol/L) or >1.5-times the baseline within 48-72 h of intravascular administration of a contrast medium. ...
Post-contrast acute kidney injury is defined as a nephropathy with an increase in serum creatinine of >0.3 mg/dL (or >26.5 mumol/L …
Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life.
Nettis E, Brussino L, Patella V, Bonzano L, Detoraki A, Di Leo E, Sirufo MM, Caruso C, Lodi Rizzini F, Conte M, Yacoub MR, Triggiani M, Ridolo E, Macchia L, Rolla G, Brancaccio R, De Paulis A, Spadaro G, Di Bona D, D'Uggento AM, Ginaldi L, Gaeta F, Nucera E, Jaubashi K, Villalta D, Dagna L, Ciotta D, Pucciarini F, Bagnasco D, Celi G, Chieco Bianchi F, Cosmi L, Costantino MT, Crivellaro MA, D'Alò S, Del Biondo P, Del Giacco S, Di Gioacchino M, Di Pietro L, Favero E, Gangemi S, Guarnieri G, Heffler E, Leto Barone MS, Lombardo C, Losa F, Matucci A, Minciullo PL, Parronchi P, Passalacqua G, Pucci S, Rossi O, Salvati L, Schiappoli M, Senna G, Vianello A, Vultaggio A, Baoran Y, Incorvaia C, Canonica GW. Nettis E, et al. Among authors: incorvaia c. Clin Mol Allergy. 2022 May 19;20(1):6. doi: 10.1186/s12948-022-00171-2. Clin Mol Allergy. 2022. PMID: 35590407 Free PMC article.
Urticaria: recommendations from the Italian Society of Allergology, Asthma and Clinical Immunology and the Italian Society of Allergological, Occupational and Environmental Dermatology.
Nettis E, Foti C, Ambrifi M, Baiardini I, Bianchi L, Borghi A, Caminati M, Canonica GW, Casciaro M, Colli L, Colombo G, Corazza M, Cristaudo A, De Feo G, De Pita' O, Di Gioacchino M, Di Leo E, Fassio F, Gangemi S, Gatta A, Hansel K, Heffler E, Incorvaia C, Napolitano M, Patruno C, Peveri S, Pigatto PD, Quecchia C, Radice A, Ramirez GA, Romita P, Rongioletti F, Rossi O, Savi E, Senna G, Triggiani M, Zucca M, Maggi E, Stingeni L. Nettis E, et al. Among authors: incorvaia c. Clin Mol Allergy. 2020 May 6;18:8. doi: 10.1186/s12948-020-00123-8. eCollection 2020. Clin Mol Allergy. 2020. PMID: 32390768 Free PMC article. Review.
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives.
Gori S, Barberis M, Bella MA, Buttitta F, Capoluongo E, Carrera P, Colombo N, Cortesi L, Genuardi M, Gion M, Guarneri V, Incorvaia L, La Verde N, Lorusso D, Marchetti A, Marchetti P, Normanno N, Pasini B, Pensabene M, Pignata S, Radice P, Ricevuto E, Sapino A, Tagliaferri P, Tassone P, Trevisiol C, Truini M, Varesco L, Russo A; AIOM-SIGU-SIBIOC-SIAPEC-IAP Working Group. Gori S, et al. Among authors: incorvaia l. Crit Rev Oncol Hematol. 2019 Aug;140:67-72. doi: 10.1016/j.critrevonc.2019.05.012. Epub 2019 May 25. Crit Rev Oncol Hematol. 2019. PMID: 31176273 Free article.
Adherence to sublingual immunotherapy: the allergists' viewpoint.
Passalacqua G, Frati F, Puccinelli P, Scurati S, Incorvaia C, Canonica GW, Hilaire C. Passalacqua G, et al. Among authors: incorvaia c. Allergy. 2009 Dec;64(12):1796-7. doi: 10.1111/j.1398-9995.2009.02136.x. Epub 2009 Aug 27. Allergy. 2009. PMID: 19712121 No abstract available.
Body Mass Index in Patients Treated with Cabozantinib for Advanced Renal Cell Carcinoma: A New Prognostic Factor?
Santoni M, Massari F, Bracarda S, Procopio G, Milella M, De Giorgi U, Basso U, Aurilio G, Incorvaia L, Martignetti A, Rizzo M, Cartenì G, Grande E, Matrana MR, Crabb SJ, Vau N, Sorgentoni G, Cimadamore A, Montironi R, Battelli N. Santoni M, et al. Among authors: incorvaia l. Diagnostics (Basel). 2021 Jan 18;11(1):138. doi: 10.3390/diagnostics11010138. Diagnostics (Basel). 2021. PMID: 33477676 Free PMC article.
24 results